Combined detection of VCA-IgA with EBNA1-IgA by ELISA enables the diagnosis of NPC patients with improved specificity and sensitivity (Fachiroh et al., 2006; Liu et al., 2012, 2020). Here, CD79A is linked to nasopharyngeal carcinoma.